MARAZION SURGERY
GWALLON LANE, MARAZION
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 35 | 53 | 66.0% | |
| HF 4 | 2011 | 34 | 43 | 79.1% | |
| HF 4 | 2012 | 42 | 54 | 77.8% | |
| HF 4 | 2013 | 46 | 59 | 78.0% | |
| HF004 | 2014 | 30 | 30 | 100.0% | |
| HF004 | 2015 | 31 | 31 | 100.0% | |
| HF004 | 2016 | 34 | 36 | 94.4% | |
| HF004 | 2017 | 35 | 37 | 94.6% | |
| HF004 | 2018 | 40 | 45 | 88.9% | |
| HF004 | 2020 | 41 | 41 | 100.0% | |
| HF006 | 2021 | 63 | 72 | 87.5% | |
| HF006 | 2022 | 64 | 65 | 98.5% | |
| HF006 | 2023 | 77 | 79 | 97.5% |
